Cargando…

Impact of Tumour Epithelial Subtype on Circulating microRNAs in Breast Cancer Patients

While a range of miRNAs have been shown to be dysregulated in the circulation of patients with breast cancer, little is known about the relationship between circulating levels and tumour characteristics. The aim of this study was to analyse alterations in circulating miRNA expression during tumour p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waters, Peadar S., Dwyer, Roisin M., Brougham, Cathy, Glynn, Claire L., Wall, Deirdre, Hyland, Peter, Duignan, Maria, McLoughlin, Mark, Newell, John, Kerin, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953120/ https://www.ncbi.nlm.nih.gov/pubmed/24626163 http://dx.doi.org/10.1371/journal.pone.0090605

Ejemplares similares

Relationship between Circulating and Tissue microRNAs in a Murine Model of Breast Cancer
por: Waters, Peadar S., et al.
Publicado: (2012)

MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid
por: Khan, Sonja, et al.
Publicado: (2015)

miR-379 Regulates Cyclin B1 Expression and Is Decreased in Breast Cancer
por: Khan, Sonja, et al.
Publicado: (2013)

MicroRNAs in Molecular Classification and Pathogenesis of Breast Tumors
por: Richard, Vinitha, et al.
Publicado: (2021)

Circulating microRNAs as Potential Biomarkers of Infectious Disease
por: Correia, Carolina N., et al.
Publicado: (2017)

Circulating microRNAs as biomarkers to assist the management of the malignant germ-cell-tumour subtype choriocarcinoma
por: Murray, Matthew J., et al.
Publicado: (2020)

Investigating the Potential and Pitfalls of EV-Encapsulated MicroRNAs as Circulating Biomarkers of Breast Cancer
por: Moloney, Brian M., et al.
Publicado: (2020)

Circulating microRNAs: promising breast cancer Biomarkers
por: Heneghan, Helen M, et al.
Publicado: (2011)

MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype
por: Tariq, Muhammad, et al.
Publicado: (2023)

Cross Platform Standardisation of an Experimental Pipeline for Use in the Identification of Dysregulated Human Circulating MiRNAs
por: Kelly, Helena, et al.
Publicado: (2015)

Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
por: McGuire, Andrew, et al.
Publicado: (2020)

Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer
por: Davey, Matthew G., et al.
Publicado: (2023)

Circulating MicroRNAs as Prognostic and Therapeutic Biomarkers in Breast Cancer Molecular Subtypes
por: Zelli, Veronica, et al.
Publicado: (2020)

Identification of Cell-Free Circulating MicroRNAs for the Detection of Early Breast Cancer and Molecular Subtyping
por: Souza, Karen C. B., et al.
Publicado: (2019)

Circulating microRNAs in aging
por: Bonafè, Massimiliano, et al.
Publicado: (2015)

Circulating microRNAs in Medicine
por: Pozniak, Tetiana, et al.
Publicado: (2022)

Evaluating the Role of Circulating MicroRNAs in Predicting Long-Term Survival Outcomes in Breast Cancer: A Prospective, Multicenter Clinical Trial
por: Davey, Matthew G, et al.
Publicado: (2022)

MicroRNAs in Metastasis and the Tumour Microenvironment
por: Solé, Carla, et al.
Publicado: (2021)

The Sodium Iodide Symporter (NIS) and Potential Regulators in Normal, Benign and Malignant Human Breast Tissue
por: Ryan, James, et al.
Publicado: (2011)

Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer: A Prospective, Multicenter Clinical Trial
por: Davey, Matthew G., et al.
Publicado: (2022)

PS193. MicroRNAs as biomarkers for treatment-resistant depression
por: Gururajan, A, et al.
Publicado: (2016)

Circulating MicroRNAs Are Not Eliminated by Hemodialysis
por: Martino, Filippo, et al.
Publicado: (2012)

Circulating MicroRNAs as Biomarkers for Sepsis
por: Benz, Fabian, et al.
Publicado: (2016)

Circulating microRNAs in Fabry Disease
por: Xiao, Ke, et al.
Publicado: (2019)

Circulating MicroRNAs in Gastrointestinal Cancer
por: Ohtsuka, Masahisa, et al.
Publicado: (2021)

Stability of circulating microRNAs in serum
por: Kupec, Tomas, et al.
Publicado: (2022)

Circulating microRNAs in Hidradenitis Suppurativa
por: De Felice, Bruna, et al.
Publicado: (2022)

Signatures of circulating microRNA in four sarcoma subtypes
por: Kosela-Paterczyk, Hanna, et al.
Publicado: (2020)

First Report of Circulating MicroRNAs in Tumour Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS)
por: Lucherini, Orso Maria, et al.
Publicado: (2013)

MicroRNAs Involved in Anti-Tumour Immunity
por: Yu, Hong W. H., et al.
Publicado: (2013)

Post-ERCP Emphysematous Cholecystitis in a Young Woman: A Rare and Potentially Fatal Complication
por: Stack, Roisin, et al.
Publicado: (2017)

MicroRNAs as Novel Biomarkers for Breast Cancer
por: Heneghan, H. M., et al.
Publicado: (2010)

Correction: First Report of Circulating MicroRNAs in Tumour Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS)
por: Lucherini, Orso Maria, et al.
Publicado: (2013)

Circulating MicroRNAs: Potential Biomarkers for Cancer
por: Yu, De-Cai, et al.
Publicado: (2011)

Circulating microRNAs as biomarkers - True Blood?
por: Schöler, Nathalie, et al.
Publicado: (2011)

MicroRNAs circulate around Alzheimer's disease
por: Smith-Vikos, Thalyana, et al.
Publicado: (2013)

Circulating MicroRNAs as Biomarkers of Acute Stroke
por: Sepramaniam, Sugunavathi, et al.
Publicado: (2014)

Intestinal and Circulating MicroRNAs in Coeliac Disease
por: Felli, Cristina, et al.
Publicado: (2017)

Circulating MicroRNAs in Cancer: Potential and Challenge
por: Cui, Mengying, et al.
Publicado: (2019)

Circulating microRNAs and Their Role in Multiple Myeloma
por: Federico, Cinzia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_djv8rc0l8ufo93a6n0sfjc1jjn